Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

Clinical trial NCT05947955 · RECRUITING

Trial details

NCT number: NCT05947955
Sponsor: BioAegis Therapeutics Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome Infections

Start date: 2024-10-03
Primary completion: 2026-10-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.